thesiliconreview15m
Medicare Expands Coverage for Eli Lilly’s Zepbound Drug
Medicare has announced the expansion of coverage for Eli Lilly’s Zepbound, a breakthrough drug in the treatment of autoimmune ...
Friedreich Ataxia Global Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End-Point Status
The "Friedreich Ataxia - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides top line data relating to the clinical trials on ...